hotspot -WSS

hotspot

author：comprehensive 2025-09-27 22:49:18 - browse：12369

Andrea Coravos, managing director at ICON, speaks at the STAT Breakthrough Summit West in San Francisco Thursday as Ida Sim, chief research informatics officer at UCSF, looks on. Sarah Gonzalez for STAT

Just because the Food and Drug Administration has given the Apple Watch and other wearable devices the OK to market the health benefits of their tracking and algorithms doesn’t mean that the data they generate are useful for either patients or their doctors, experts said Thursday at the STAT Breakthrough Summit West in San Francisco.

“Yesterday, I saw a patient with type 2 diabetes who has a continuous glucose monitor, and so she’s been tracking her blood sugar every five minutes,” said Ida Sim, a primary care physician and chief research informatics officer at the University of California, San Francisco. “[I] sat with her for almost an hour yesterday. I couldn’t get to her CGM data — she had it on her phone, but the report goes into a website that I didn’t have the login to, and it hadn’t been downloaded into my electronic medical record. So all this tracking data, I didn’t have it.”

Not only do clinicians not have the ability to access data that their patients want to use to guide their care, but primary care doctors often don’t know how to interpret that firehose of data, said Sim. She asked some of her endocrinology research colleagues how they use that data and they explained the calculations needed to create biomarker metrics from them. That made the data largely useless to her as a doctor, and it was frustrating.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Biden administration opens offers in Medicare drug price negotiations

Wikipedia

WSS

Care demand spikes challenge UnitedHealth’s provider arm

General Catalyst, Summa Health deal will turn on physician buy

Apple Vision Pro: A first look at health apps on the new VR headset

Celiac disease study examines precisely how gluten triggers injury

Congress: Eradicate hepatitis C and reduce the deficit

Juul spent big to court Black leaders to promote its e

focus

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

knowledge

Hollywood unions extend contract negotiations for actors

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Congress likely to miss an opportunity to fix drug shortages issue

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Celiac disease study examines precisely how gluten triggers injury

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Michigan AG announces felony charges against 'fake electors' in 2020 election plot

Duchenne breakthrough therapy leaves behind pioneering families

Novo Nordisk to expand supply of Wegovy for U.S. patients

focus

Grail faces three suits alleging harassment, retaliation

Europe sees delivery challenges ahead on Alzheimer's therapies

The new HIV moral panic

Special counsel informs Trump he is target in probe of efforts to overturn 2020 election

Vertigo drug brings hope for rare neuron disorder, Niemann

The lessons of Aduhelm, an Alzheimer's drug that was not to be

Wikipedia

Wikipedia

entertainment

entertainment